Lana Chahine, MD, PhD
Professor of Clin Neurology
Neurology
School of Medicine

Publications (146)

Top publication keywords:
Multiple System AtrophyFatiguealpha-SynucleinLewy Body DiseaseSubmandibular GlandParkinson DiseaseProdromal SymptomsREM Sleep Behavior DisorderDisease ProgressionSalivaAutonomic Nervous System DiseasesNeurodegenerative DiseasesColonDopamine Plasma Membrane Transport ProteinsDopamine

• Slow-SPEED: protocol for three randomised trials of remotely delivered exercise to prevent Parkinson's disease.
  NPJ Parkinson's disease 2026 Oosterhof TH, Mitchell E, Ascherio A, Aslibekyan S, Azoidou V, Beasley K, Ben-Shlomo Y, Bunnik E, Carroll C, Chahine L, Corcos D, Janssen Daalen JM, van Dijk KD, Dijkstra BW, Dommershuijsen L, Dorsey …
• Brain-Aggregated and Body-Aggregated Alpha-Synuclein in Lewy Body Disease: Sowing Initial Seeds of Understanding.
  Neurology 2026 Coughlin DG, Chahine LM
• A Bayesian network analysis of gait speed change upon transition to uneven surfaces in older adults.
  The journals of gerontology. Series A, Biological sciences and medical sciences 2026 Song Y, Rosano C, Chahine LM, Rosso AL, Ambrosio F, Bohnen N, Chen Z, Kim S
• Outcomes in Long-Term Follow-Up of Sporadic Parkinson's Disease in the Parkinson's Progression Markers Initiative.
  Annals of neurology 2026 Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey CS, Lafontant DE, Xiao Y, Tanner CM, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Galasko D, Picillo M, Siderowf A, Tropea TF,…
• Identification and Enrollment of Individuals Prior to Parkinson's Disease Diagnosis: Biomarker-Driven Adaptive Eligibility and Enrollment into the Parkinson's Progression Markers Initiative.
  Annals of neurology 2026 Brown EG, Chahine LM, Dobkin RD, Simuni T, Foroud T, Heathers LEA, Tropea TF, Stanley CE, McMahon BA, Brüggemann N, Klein C, Postuma RB, Johnson NS, Gochanour C, Caspell-Garcia C, Kurth R, Brumm MC, …

Show all (141 more) Hide

• Cognitive Impairment in Parkinson's Disease: Contributions from the Parkinson's Progression Markers Initiative.
  Annals of neurology 2026 Weintraub D, Dobkin RD, York MK, Chahine LM, Tropea TF, Marek K, Parkinson's Progression Markers Initiative
• Expanding PPMI through Remote Data Acquisition and Analysis: Early Success and Future Growth with myPPMI.
  Annals of neurology 2026 Tanner CM, Stanley CE, Brown EG, Chahine LM, Weintraub D, Dobkin RD, Poewe W, Tolosa E, Marras C, Schade S, Chou KL, Pavese N, Coffey CS, Brumm MC, Kurth R, Noyce AJ, Gonzalez-Latapi P, Matthews-McGee…
• Practical approaches to inclusive recruitment practices in Parkinson's disease research.
  Journal of Parkinson's disease 2026 Chahine LM, Louie N, Disbrow E, Marbach A, Augenbraun S, Nguyen BT, Johnson-Turbes A, Parry C, Avripas S, Chandra S, Dean M, Foster ER, Hall D, Hinson V, Kilbane C, Norris SA, Rawls A, Jonas C, Shamim…
• Biologic Frameworks for Synucleinopathies: Contributions of the Parkinson's Progression Markers Initiative.
  Annals of neurology 2026 Chahine LM, Alcalay RN, Brown EG, Chowdhury S, Coffey CS, Foroud T, Frasier M, Galasko D, Merchant KM, Mollenhauer B, Tolosa E, Pavese N, Tropea TF, Marek K, Simuni T, Parkinson's Progression Markers …
• Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.
  Brain : a journal of neurology 2026 Akçimen F, Paquette K, Wild Crea P, Step K, Waldo E, Koretsky MJ, Saffie-Awad P, Achoru C, Taiwo F, Ozomma S, Onwuegbuzie G, Khani M, Grant S, Owolabi L, Okereke C, Oshinaike O, Iwuozo E, Akerman SC, …
• Return of Individual Research Information in the Parkinson's Progression Markers Initiative.
  Annals of neurology 2026 Tropea TF, Brodkin K, Brumm MC, Carley JK, Destro C, Flagg E, Heathers LEA, Henry B, Lemon LP, Kuhl MM, McMahon BA, Miller M, Myers H, Stanley CE, Talarico JM, Pico C, Chahine LM, Siderowf A, Marek K,…
• Prodromal Lewy Body Disorder Features in REM Sleep Behavior Disorder With Biomarker-Defined Synucleinopathy.
  Annals of clinical and translational neurology 2026 Weintraub D, York MK, Dobkin R, Nair AR, Kurth R, Lafontant DE, Caspell-Garcia C, Alcalay RN, Brown EG, Chahine LM, Coffey C, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, …
• Clinical Progression in Alpha-Synuclein Positive LRRK2-PD and Sporadic Parkinson's Disease: A Longitudinal Analysis.
  Movement disorders clinical practice 2026 Morse LA, Choi SH, Gochanour C, Lafontant DE, Chahine LM, Merchant KM, Wendelberger B, Simuni T, Parkinson's Progression Markers Initiative
• Striatal Dopaminergic Neurotransmission, Striato-Cortical Functional Connectivity, and Motivation in Community-Dwelling Older Adults.
  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2026 Song Y, Cawthon PM, Zhai X, Huppert TJ, Rosso AL, Butters MA, Chahine LM, Lopresti BJ, Royse SK, Rosano C
• International Parkinson and Movement Disorder Society Clinical Outcome Assessments are Available in REDCap.
  Movement disorders : official journal of the Movement Disorder Society 2026 Fuller RLM, Monje MHG, Chahine LM, Delgado EC, Dujardin K, Elavarasi A, Fearon C, Fitzer-Attas CJ, Groppa S, Jha A, Raji HK, Nirenberg MJ, Lloret SP, Poon C, Schneider R, Turner T, Youn J, Mestre TA, …
• Five-Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease.
  Annals of clinical and translational neurology 2026 Gonzalez-Latapi P, Gochanour C, Choi SH, Cho H, Caspell-Garcia C, Coffey C, Brumm M, Lafontant DE, Xiao Y, Tropea T, Seibyl J, Tanner C, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Siderowf A, Marek…
• Striatal dopamine and skeletal muscle energy metabolism in older adults.
  The journals of gerontology. Series A, Biological sciences and medical sciences 2026 Rosano C, Bohnen NI, Lopresti B, Chahine LM, Barnes HN, Studenski SL, Glynn NW, Newman AB, Marcinek DJ, Hepple RT, Coen PM
• Biological characteristics of individuals with REM sleep behavior disorder: A multicenter prospective longitudinal cohort.
  Parkinsonism & related disorders 2026 Feuerstein J, Brown E, Chahine L, Erick-Lafontant D, Gochanour C, Marshall M, Weintraub D, Simuni T, Amara A, Parkinson's Progression Markers Initiative
• Clinical and Imaging Characteristics of Parkinson's Disease with Negative Alpha-Synuclein Seed Amplification Assay.
  Movement disorders : official journal of the Movement Disorder Society 2026 Brooker SM, Pasquini J, Choi SH, Lafontant DE, Fereshtehnejad SM, Zeighami Y, Grillo P, Riboldi GM, Azizi H, Moqadam R, Kang UJ, Nudelman KNH, Siderowf A, Tanner CM, Tropea TF, Foroud T, Chahine LM, …
• Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease.
  Communications medicine 2026 Kopal J, Vo A, Tao Q, Simuni T, Chahine LM, Bzdok D, Dagher A
• Prodromal features and risk of neurodegenerative disorders diagnosis in outpatients with REM sleep behavior disorder.
  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025 Chahine LM, Newman A, Boyce RD, Brooks MM
• Parkinson's disease: emerging opportunities through global collaboration.
  Lancet (London, England) 2025 Singleton A, Blauwendraat C, Morris HR, Noyce AJ, Klein C, Mata I, Okubadejo N, Periñan MT, Chahine LM
• Features of Prodromal Parkinson Disease and Dopaminergic Neurotransmission in Community-Dwelling Older Adults.
  Neurology 2025 Chahine L, Rosso AL, Troidl I, Ganguli M, Newman AB, Lopresti BJ, Allen K, Royse SK, Mosovsky S, Ratner E, Dholakia G, Bohnen NI, Rosano C
• Nigrostriatal dopaminergic integrity in relation to prefrontal cortex activity and gait performance during dual-task walking in older adults.
  The journals of gerontology. Series A, Biological sciences and medical sciences 2025 Rosso AL, Baillargeon EM, Bohnen NI, Lopresti BJ, Huppert TJ, Chahine LM, Jacobsen E, Rosano C
• Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder.
  Annals of neurology 2025 Weintraub D, Nair AR, Kurth R, Brumm MC, Kohnen C, York MK, Dobkin RD, Marek K, Tanner C, Simuni T, Siderowf A, Galasko D, Chahine LM, Coffey C, Merchant K, Poston KL, Foroud T, Mollenhauer B, Brown …
• Reply to: "Refutation of the αSyn-SAA-Based Staging for Parkinson's Progression (Neuronal α-Synuclein Disease-Integrated Staging System [NSD-ISS])".
  Movement disorders : official journal of the Movement Disorder Society 2025 Simuni T, Chahine LM, Poston KL, Kopil CM, Weintraub D, Dunn B, Marek K
• Nigrostriatal dopaminergic neurotransmission and resilience to peripheral systemic risk factors for gait slowing upon transition to uneven surfaces in older adult.
  Aging brain 2025 Chahine LM, Rosso A, Troidl I, Ganguli M, Newman A, Cummings S, Studenski S, Lopresti B, Royse S, Huppert T, Redfern M, Sparto PJ, Bohnen NI, Rosano C
• Striatal Dopamine and Skeletal Muscle Energy Metabolism in Older Adults.
  medRxiv : the preprint server for health sciences 2025 Rosano C, Bohnen NI, LoPresti B, Chahine LM, Barnes HN, Studenski SL, Glynn NW, Newman AB, Marcinek DJ, Hepple RT, Coen P
• Mesocorticolimbic dopaminergic innervation modulates Levodopa-related improvements in gait in older slow walking Adults: A [11C]PE2I PET study.
  Clinical parkinsonism & related disorders 2025 Paalanen N, Roytman S, Emde Boas MV, Biddix A, Luker A, Michalakis F, Carli G, Kanel P, Pongmala C, Koeppe R, Chahine LM, Rosano C, Bohnen NI
• Neuronal α-Synuclein Disease Stage Progression over 5 Years.
  Movement disorders : official journal of the Movement Disorder Society 2025 Simuni T, Gochanour C, Nair AR, Brumm MC, Coffey C, Poston KL, Chahine LM, Weintraub D, Tanner CM, Gonzalez-Latapi P, Kopil CM, Xiao Y, Chowdhury S, Dam T, Pagano G, Stephenson D, Siderowf A, Dunn B, …
• Predicting CSF α-Synuclein Seed Amplification Assay Status From Demographics and Clinical Data.
  Neurology open access 2025 Venuto CS, Herbst K, Chahine L, Kieburtz KD
• Application of new biologic disease criteria for synucleinopathies to the systemic synuclein sampling study cohort.
  NPJ Parkinson's disease 2025 Chahine LM, Brumm MC, Nair AR, Mosovsky S, Polinski NK, Beach TG, Mollenhauer B, Adler CH, Systemic Synuclein Sampling Study
• Fears and uncertainties of people with Parkinson's disease.
  Journal of Parkinson's disease 2025 Trahair ED, Steiger D, Lowe N, Rapoport R, Kelliher C, Benvengo S, Kopil C, Chahine LM, Marras C, Mantri S
• Carriers of LRRK2 pathogenic variants show a milder, anatomically distinct brain signature of Parkinson's disease.
  medRxiv : the preprint server for health sciences 2025 Kopal J, Vo A, Tao Q, Simuni T, Chahine LM, Bzdok D, Dagher A
• Predicting Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data.
  medRxiv : the preprint server for health sciences 2025 Venuto CS, Herbst K, Chahine LM, Kieburtz K
• LRRK2-associated parkinsonism with and without in vivo evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization.
  Brain communications 2025 Chahine LM, Lafontant DE, Choi SH, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN, Merchant K, Nudelman KNH, Dagher A, Vo A, Tao Q, Venuto CS, Kieburtz K, Poston KL, Bressman S, Gonzalez-…
• Nigrostriatal dopaminergic integrity in relation to prefrontal cortex activity and gait performance during dual-task walking in older adults.
  medRxiv : the preprint server for health sciences 2025 Rosso AL, Baillargeon EM, Bohnen NI, Lopresti BJ, Huppert TJ, Chahine LM, Jacobsen E, Rosano C
• Validation of automated detection of REM sleep without atonia using in-laboratory and in-home recordings.
  Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2025 Levendowski DJ, Chahine LM, Lewis SJG, Finstuen TJ, Galbiati A, Berka C, Mosovsky S, Parikh H, Anderson J, Walsh CM, Lee-Iannotti JK, Neylan TC, Strambi LF, Boeve BF, St Louis EK
• Large-scale genetic characterization of Parkinson's disease in the African and African admixed populations.
  medRxiv : the preprint server for health sciences 2025 Akçimen F, Paquette K, Crea PW, Saffie-Awad P, Achoru C, Taiwo F, Ozomma S, Onwuegbuzie G, Khani M, Grant S, Owolabi L, Okereke C, Oshinaike O, Iwuozo E, Lee PS, Oyakhire S, Osemwegie N, Daida K, …
• Effects of 6 months of endurance exercise on motor function, exercise capacity, and autonomic function based on presence of autonomic dysfunction in individuals with early Parkinson's disease.
  Journal of Parkinson's disease 2025 Griffith GJ, Mehta N, Lamotte G, McKee KE, Suttman E, Haus JM, Joslin E, Balfany K, Kohrt WM, Christiansen CL, Melanson EL, Chahine LM, Christou DD, Patterson CG, Corcos DM
• Concordance and test-retest consistency of sleep biomarker-based neurodegenerative disorder profiling.
  Scientific reports 2024 Levendowski DJ, Tsuang D, Chahine LM, Walsh CM, Berka C, Lee-Iannotti JK, Salat D, Fischer C, Mazeika G, Boeve BF, Strambi LF, Lewis SJG, Neylan TC, St Louis EK
• Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha-Synuclein Disease.
  Annals of neurology 2024 Brown EG, Chahine LM, Siderowf A, Gochanour C, Kurth R, Marshall MJ, Caspell-Garcia C, Brumm MC, Stanley CE, Korell M, McMahon B, Kuhl M, Fabrizio K, Heathers L, Concha-Marambio L, Soto C, Chowdhury S…
• Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia.
  medRxiv : the preprint server for health sciences 2024 Weintraub D, Nair AR, Kurth R, Brumm MC, York MK, Dobkin R, Marek K, Tanner C, Simuni T, Siderowf A, Galasko D, Chahine LM, Coffey C, Merchant K, Poston KL, Foroud T, Mollenhauer B, Brown EG, Kieburtz…
• Environmental Risk Factors for Parkinson's Disease: A Critical Review and Policy Implications.
  Movement disorders : official journal of the Movement Disorder Society 2024 Atterling Brolin K, Schaeffer E, Kuri A, Rumrich IK, Schumacher Schuh AF, Darweesh SKL, Kaasinen V, Tolppanen AM, Chahine LM, Noyce AJ
• What Parkinson's disease patients say in their own words about their mood and anxiety symptoms.
  Parkinsonism & related disorders 2024 Anderson KE, Marras C, Amara A, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Weintraub D, Shoulson I, Arbatti L
• REM Sleep Behavior Disorder Diagnostic Code Accuracy and Implications in the Real-World Setting.
  Neurology. Clinical practice 2024 Chahine LM, Ratner D, Palmquist A, Dholakia G, Newman AB, Boyce RD, Rosano C, Brooks M
• Higher Striatal Dopamine is Related With Lower Physical Performance Fatigability in Community-Dwelling Older Adults.
  The journals of gerontology. Series A, Biological sciences and medical sciences 2024 Rosano C, Chahine LM, Gay EL, Coen PM, Bohnen NI, Studenski SA, LoPresti B, Rosso AL, Huppert T, Newman AB, Royse SK, Kritchevsky SB, Glynn NW
• The Black and African American Connections to Parkinson's Disease (BLAAC PD) study protocol.
  BMC neurology 2024 Chahine LM, Louie N, Solle J, Akçimen F, Ameri A, Augenbraun S, Avripas S, Breaux S, Causey C, Chandra S, Dean M, Disbrow EA, Fanty L, Fernandez J, Foster ER, Furr Stimming E, Hall D, Hinson V, …
• Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson's Disease.
  medRxiv : the preprint server for health sciences 2024 Gonzalez-Latapi P, Gochanour C, Cho H, Ho Choi S, Caspell-Garcia C, Coffey C, Brumm M, Lafontant DE, Xiao Y, Tanner C, Venuto CS, Kieburtz K, Chahine LM, Poston KL, Siderowf A, Marek K, Simuni T
• Neuronal alpha-Synuclein Disease integrated staging system performance in PPMI, PASADENA, and SPARK baseline cohorts.
  NPJ Parkinson's disease 2024 Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz …
• Neuronal alpha-Synuclein Disease Integrated Staging System performance in PPMI, PASADENA, and SPARK baseline cohorts.
  medRxiv : the preprint server for health sciences 2024 Dam T, Pagano G, Brumm MC, Gochanour C, Poston KL, Weintraub D, Chahine LM, Coffey C, Tanner CM, Kopil CM, Xiao Y, Chowdhury S, Concha-Marambio L, DiBiaso P, Foroud T, Frasier M, Jennings D, Kieburtz …
• Long-Term Dementia Risk in Parkinson Disease.
  Neurology 2024 Gallagher J, Gochanour C, Caspell-Garcia C, Dobkin RD, Aarsland D, Alcalay RN, Barrett MJ, Chahine L, Chen-Plotkin AS, Coffey CS, Dahodwala N, Eberling JL, Espay AJ, Leverenz JB, Litvan I, Mamikonyan …
• LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates.
  medRxiv : the preprint server for health sciences 2024 Chahine LM, Lafontant DE, Ho Choi S, Iwaki H, Blauwendraat C, Singleton AB, Brumm MC, Alcalay RN, Merchant K, Nudelman KNH, Dagher A, Vo A, Tao Q, Venuto CS, Kieburtz K, Poston KL, Bressman S, …
• Cognitive Symptoms in Cross-Sectional Parkinson Disease Cohort Evaluated by Human-in-the-Loop Machine Learning and Natural Language Processing.
  Neurology. Clinical practice 2024 Purks JL, Arbatti L, Hosamath A, Amara AW, Anderson KE, Chahine L, Eberly SW, Kinel D, Mantri S, Mathur S, Oakes D, Standaert DG, Weintraub D, Shoulson I, Marras C
• Concerns with the new biological research criteria for synucleinopathy - Authors' reply.
  The Lancet. Neurology 2024 Simuni T, Chahine LM, Weintraub D, Poston KM, Kopil CM, Dunn B, Marek K
• Association between Subjective Cognitive Complaints and Incident Functional Impairment in Parkinson's Disease.
  Movement disorders : official journal of the Movement Disorder Society 2024 Weintraub D, Marras C, Amara A, Anderson KE, Chahine LM, Eberly S, Hosamath A, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Shoulson I, Arbatti L
• A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research.
  The Lancet. Neurology 2024 Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M, Chowdhury S, Coffey C, Concha-Marambio L, Dam T, DiBiaso P, Foroud T, Frasier M, Gochanour C, Jennings D, Kieburtz K, Kopil CM, …
• Chronotropic Incompetence During Exercise Testing as a Marker of Autonomic Dysfunction in Individuals with Early Parkinson's Disease.
  Journal of Parkinson's disease 2024 Griffith G, Lamotte G, Mehta N, Fan P, Nikolich J, Springman V, Suttman E, Joslin E, Balfany K, Dunlap M, Kohrt WM, Christiansen CL, Melanson EL, Josbeno D, Chahine LM, Patterson CG, Corcos DM
• In Their Own Words: Fears Expressed by People with Parkinson's Disease in an Online Symptom Database.
  Journal of Parkinson's disease 2024 Mantri S, Purks JL, Kinel D, Arbatti L, Hosamath A, Allen A, Amara A, Anderson K, Chahine LM, Eberly S, Mathur S, Standaert D, Oakes D, Weintraub D, Shoulson I, Marras C
• Internal tremor in people with Parkinson's Disease: Demographic characteristics and comorbid symptoms.
  Clinical parkinsonism & related disorders 2023 Chahine LM, Arbatti L, Hosamath A, Amara A, Anderson KE, Purks J, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Standaert DG, Weintraub D, Shoulson I, Marras C
• Physical Activity and the Risk of Parkinson Disease: Moving in the Right Direction.
  Neurology 2023 Chahine LM, Darweesh SKL
• Course of Impulse Control Disorder Symptoms in Parkinson's Disease: Deep Brain Stimulation Versus Medications.
  Movement disorders clinical practice 2023 Hernandez-Con P, Lin I, Mamikonyan E, Deeb W, Feldman R, Althouse A, Barmore R, Eisinger RS, Spindler M, Okun MS, Weintraub D, Chahine LM
• Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study.
  The Lancet. Neurology 2023 Siderowf A, Concha-Marambio L, Lafontant DE, Farris CM, Ma Y, Urenia PA, Nguyen H, Alcalay RN, Chahine LM, Foroud T, Galasko D, Kieburtz K, Merchant K, Mollenhauer B, Poston KL, Seibyl J, Simuni T, …
• Impact of the Dopamine System on Long-Term Cognitive Impairment in Parkinson Disease: An Exploratory Study.
  Movement disorders clinical practice 2023 Weintraub D, Picillo M, Cho HR, Caspell-Garcia C, Blauwendraat C, Brown EG, Chahine LM, Coffey CS, Dobkin RD, Foroud T, Galasko D, Kieburtz K, Marek K, Merchant K, Mollenhauer B, Poston KL, Simuni T, …
• International Consensus Statement on Obstructive Sleep Apnea.
  International forum of allergy & rhinology 2023 Chang JL, Goldberg AN, Alt JA, Mohammed A, Ashbrook L, Auckley D, Ayappa I, Bakhtiar H, Barrera JE, Bartley BL, Billings ME, Boon MS, Bosschieter P, Braverman I, Brodie K, Cabrera-Muffly C, Caesar R, …
• Central and peripheral α-synuclein in Parkinson disease detected by seed amplification assay.
  Annals of clinical and translational neurology 2023 Chahine LM, Beach TG, Adler CH, Hepker M, Kanthasamy A, Appel S, Pritzkow S, Pinho M, Mosovsky S, Serrano GE, Coffey C, Brumm MC, Oliveira LMA, Eberling J, Mollenhauer B, Systemic Synuclein Sampling …
• LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts.
  NPJ Parkinson's disease 2023 Merchant KM, Simuni T, Fedler J, Caspell-Garcia C, Brumm M, Nudelman KNH, Tengstrandt E, Hsieh F, Alcalay RN, Coffey C, Chahine L, Foroud T, Singleton A, Weintraub D, Hutten S, Sherer T, Mollenhauer B…
• Parkinson's Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson's Disease Progression.
  Journal of Parkinson's disease 2023 Brumm MC, Siderowf A, Simuni T, Burghardt E, Choi SH, Caspell-Garcia C, Chahine LM, Mollenhauer B, Foroud T, Galasko D, Merchant K, Arnedo V, Hutten SJ, O'Grady AN, Poston KL, Tanner CM, Weintraub D, …
• Proposal for a Biologic Staging System of Parkinson's Disease.
  Journal of Parkinson's disease 2023 Chahine LM, Merchant K, Siderowf A, Sherer T, Tanner C, Marek K, Simuni T
• Role of novel endpoints and evaluations of response in Parkinson disease.
  Handbook of clinical neurology 2023 Chahine LM, Simuni T
• What Patients Say: Large-Scale Analyses of Replies to the Parkinson's Disease Patient Report of Problems (PD-PROP).
  Journal of Parkinson's disease 2023 Marras C, Arbatti L, Hosamath A, Amara A, Anderson KE, Chahine LM, Eberly S, Kinel D, Mantri S, Mathur S, Oakes D, Purks JL, Standaert DG, Tanner CM, Weintraub D, Shoulson I
• Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort.
  NPJ Parkinson's disease 2022 Simuni T, Merchant K, Brumm MC, Cho H, Caspell-Garcia C, Coffey CS, Chahine LM, Alcalay RN, Nudelman K, Foroud T, Mollenhauer B, Siderowf A, Tanner C, Iwaki H, Sherer T, Marek K, Parkinson’s …
• Study in Parkinson's disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial.
  Trials 2022 Patterson CG, Joslin E, Gil AB, Spigle W, Nemet T, Chahine L, Christiansen CL, Melanson E, Kohrt WM, Mancini M, Josbeno D, Balfany K, Griffith G, Dunlap MK, Lamotte G, Suttman E, Larson D, Branson C, …
• Prodromal α-Synucleinopathies.
  Continuum (Minneapolis, Minn.) 2022 Chahine LM
• Selected autonomic signs and symptoms as risk markers for phenoconversion and functional dependence in prodromal Parkinson's disease.
  Clinical autonomic research : official journal of the Clinical Autonomic Research Society 2022 Miller-Patterson C, Hsu JY, Chahine LM, Morley JF, Willis AW
• Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures.
  Neurology 2022 Mirelman A, Siderowf A, Chahine L
• Early Autonomic Symptoms Predict Functional Decline in Parkinson's Disease Independent of Dopaminergic Therapy.
  Neuro-degenerative diseases 2022 Miller-Patterson C, Hsu JY, Chahine LM
• Mild Parkinsonian Signs, Energy Decline, and Striatal Volume in Community-Dwelling Older Adults.
  The journals of gerontology. Series A, Biological sciences and medical sciences 2022 Tian Q, Ehrenkranz R, Rosso AL, Glynn NW, Chahine LM, Hengenius J, Zhu X, Rosano C
• Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence.
  Acta neuropathologica communications 2022 Signaevsky M, Marami B, Prastawa M, Tabish N, Iida MA, Zhang XF, Sawyer M, Duran I, Koenigsberg DG, Bryce CH, Chahine LM, Mollenhauer B, Mosovsky S, Riley L, Dave KD, Eberling J, Coffey CS, Adler CH, …
• Surveying Global Availability of Parkinson's Disease Treatment.
  Journal of Parkinson's disease 2022 Goh ZHK, Cheong JLY, Marras C, Tanner CM, Kasten M, Korczyn AD, Chahine L, Lo R, Noyce AJ, Movement Disorders Society Epidemiology Study Group
• Demographic Influences on the Relationship Between Fatigue and Quality of Life in Parkinson's Disease.
  Movement disorders clinical practice 2021 Mantri S, Chahine LM, Nabieva K, Feldman R, Althouse A, Torsney B, Albert SM, Kopil C, Marras C
• Diffusion Tensor Imaging of the Olfactory System in Older Adults With and Without Hyposmia.
  Frontiers in aging neuroscience 2021 Felix C, Chahine LM, Hengenius J, Chen H, Rosso AL, Zhu X, Cao Z, Rosano C
• Use of Figurative Language by People With Parkinson Disease to Describe "Off" Periods: Clear as Mud.
  Neurology. Clinical practice 2021 Chahine LM, Edison B, Daeschler M, Siddiqi B, Kopil C, Marras C, Mantri S
• Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning.
  The Lancet. Digital health 2021 Severson KA, Chahine LM, Smolensky LA, Dhuliawala M, Frasier M, Ng K, Ghosh S, Hu J
• The Experience of OFF Periods in Parkinson's Disease: Descriptions, Triggers, and Alleviating Factors.
  Journal of patient-centered research and reviews 2021 Mantri S, Lepore M, Edison B, Daeschler M, Kopil CM, Marras C, Chahine LM
• Author Response: In Vivo Distribution of α-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease.
  Neurology 2021 Beach T, Chahine LM, Adler CH, Mollenhauer B
• Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease.
  Movement disorders : official journal of the Movement Disorder Society 2021 Kremer T, Taylor KI, Siebourg-Polster J, Gerken T, Staempfli A, Czech C, Dukart J, Galasko D, Foroud T, Chahine LM, Coffey CS, Simuni T, Weintraub D, Seibyl J, Poston KL, Toga AW, Tanner CM, Marek K, …
• The experience of care partners of patients with Parkinson's disease psychosis.
  PloS one 2021 Mantri S, Klawson E, Albert S, Rapoport R, Precht C, Glancey S, Daeschler M, Mamikonyan E, Kopil CM, Marras C, Chahine LM
• Changes in Self-Reported Energy Levels in Prodromal Parkinson's Disease.
  Movement disorders : official journal of the Movement Disorder Society 2021 Chahine LM, Zhu X, Ehrenkranz R, Chen H, Glynn NW, Rosano C
• Contribution of neuropsychiatric symptoms in Parkinson's disease to different domains of caregiver burden.
  Journal of neurology 2021 Chahine LM, Feldman R, Althouse A, Torsney B, Alzyoud L, Mantri S, Edison B, Albert S, Daeschler M, Kopil C, Marras C
• Triggers and alleviating factors for fatigue in Parkinson's disease.
  PloS one 2021 Lin I, Edison B, Mantri S, Albert S, Daeschler M, Kopil C, Marras C, Chahine LM
• Knowledge, Responsibilities, and Peer Advice From Care Partners of Patients With Parkinson Disease Psychosis.
  Frontiers in neurology 2021 Mantri S, Edison B, Alzyoud L, Albert SM, Daeschler M, Kopil C, Marras C, Chahine LM
• Toward e-Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales.
  Movement disorders clinical practice 2020 Monje MHG, Fuller RLM, Cubo E, Mestre TA, Tan AH, Stout JC, Ali S, Chahine L, Dujardin K, Fitzer-Attas CJ, Youn J, Bloem BR, Horak FB, Merola A, Reilmann R, Paul SS, Dorsey ER, Maetzler W, Espay AJ, …
• Dopamine transporter imaging predicts clinically-defined α-synucleinopathy in REM sleep behavior disorder.
  Annals of clinical and translational neurology 2020 Chahine LM, Brumm MC, Caspell-Garcia C, Oertel W, Mollenhauer B, Amara A, Fernandez-Arcos A, Tolosa E, Simonet C, Hogl B, Videnovic A, Hutten SJ, Tanner C, Weintraub D, Burghardt E, Coffey C, Cho HR, …
• Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
  Annals of clinical and translational neurology 2020 Alcalay RN, Wolf P, Chiang MSR, Helesicova K, Zhang XK, Merchant K, Hutten SJ, Scherzer C, Caspell-Garcia C, Blauwendraat C, Foroud T, Nudelman K, Gan-Or Z, Simuni T, Chahine LM, Levy O, Zheng D, Li G…
• Sleep and circadian rhythms in the treatment, trajectory, and prevention of neurodegenerative disease.
  Neurobiology of disease 2020 Wilckens KA, Chahine LM
• Reply to Comment on: The Most Bothersome Aspects of off Periods Reported by Individuals with Parkinson's Disease.
  Movement disorders clinical practice 2020 Chahine LM, Edison B, Mantri S, Kopil C, Marras C
• Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
  Movement disorders : official journal of the Movement Disorder Society 2020 Mollenhauer B, Dakna M, Kruse N, Galasko D, Foroud T, Zetterberg H, Schade S, Gera RG, Wang W, Gao F, Frasier M, Chahine LM, Coffey CS, Singleton AB, Simuni T, Weintraub D, Seibyl J, Toga AW, Tanner …
• In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease.
  Neurology 2020 Chahine LM, Beach TG, Brumm MC, Adler CH, Coffey CS, Mosovsky S, Caspell-Garcia C, Serrano GE, Munoz DG, White CL, Crary JF, Jennings D, Taylor P, Foroud T, Arnedo V, Kopil CM, Riley L, Dave KD, …
• Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease.
  Annals of neurology 2020 Irwin DJ, Fedler J, Coffey CS, Caspell-Garcia C, Kang JH, Simuni T, Foroud T, Toga AW, Tanner CM, Kieburtz K, Chahine LM, Reimer A, Hutten S, Weintraub D, Mollenhauer B, Galasko DR, Siderowf A, Marek …
• Sex Disparities in Autonomic Symptom Treatment in Parkinson's Disease.
  Movement disorders clinical practice 2020 Miller-Patterson C, Edwards KA, Chahine LM
• Subjective Cognitive Complaint in Parkinson's Disease Patients With Normal Cognition: Canary in the Coal Mine?
  Movement disorders : official journal of the Movement Disorder Society 2020 Purri R, Brennan L, Rick J, Xie SX, Deck BL, Chahine LM, Dahodwala N, Chen-Plotkin A, Duda JE, Morley JF, Akhtar RS, Trojanowski JQ, Siderowf A, Weintraub D
• Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease.
  Annals of clinical and translational neurology 2020 Weintraub D, Caspell-Garcia C, Simuni T, Cho HR, Coffey CS, Aarsland D, Alcalay RN, Barrett MJ, Chahine LM, Eberling J, Espay AJ, Hamilton J, Hawkins KA, Leverenz J, Litvan I, Richard I, Rosenthal LS,…
• Parkinson's disease in the MENASA countries.
  The Lancet. Neurology 2020 Khalil H, Chahine L, Siddiqui J, Aldaajani Z, Bajwa JA
• The Most Bothersome Aspects of Off Periods Reported by Individuals with Parkinson's Disease.
  Movement disorders clinical practice 2020 Chahine LM, Edison B, Daeschler M, Mantri S, Kahl S, Rapoport R, Goyle A, Precht C, Kopil C, Marras C
• Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.
  Movement disorders : official journal of the Movement Disorder Society 2020 Simuni T, Brumm MC, Uribe L, Caspell-Garcia C, Coffey CS, Siderowf A, Alcalay RN, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Nudelman K, Tosun-Turgut D, Poston K, …
• Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person.
  Journal of Parkinson's disease 2020 Chahine LM, Chin I, Caspell-Garcia C, Standaert DG, Brown E, Smolensky L, Arnedo V, Daeschler D, Riley L, Korell M, Dobkin R, Amondikar N, Gradinscak S, Shoulson I, Dean M, Kwok K, Cannon P, Marek K, …
• Innovative Recruitment Strategies to Increase Diversity of Participation in Parkinson's Disease Research: The Fox Insight Cohort Experience.
  Journal of Parkinson's disease 2020 Dobkin RD, Amondikar N, Kopil C, Caspell-Garcia C, Brown E, Chahine LM, Marras C, Dahodwala N, Mantri S, Standaert DG, Dean M, Shoulson I, Marek K, Katz A, Korell M, Riley L, Tanner CM, Fox Insight …
• Parkinson's Disease in the Middle East, North Africa, and South Asia: Consensus from the International Parkinson and Movement Disorder Society Task Force for the Middle East.
  Journal of Parkinson's disease 2020 Khalil H, Chahine LM, Siddiqui J, Salari M, El-Jaafary S, Aldaajani Z, Abu Al-Melh M, Mohammad TM, Abu Snineh M, Syed NA, Bhatt M, Habib MA, Habahbeh M, Tabbal SD, Jeon B, Bajwa JA
• The Effect of the COVID-19 Pandemic on People with Parkinson's Disease.
  Journal of Parkinson's disease 2020 Brown EG, Chahine LM, Goldman SM, Korell M, Mann E, Kinel DR, Arnedo V, Marek KL, Tanner CM
• Understanding the Lexicon of Fatigue in Parkinson's Disease.
  Journal of Parkinson's disease 2020 Mantri S, Klawson E, Albert S, Nabieva K, Lepore M, Kahl S, Daeschler M, Mamikonyan E, Kopil C, Marras C, Chahine LM
• Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
  The Lancet. Neurology 2019 Simuni T, Uribe L, Cho HR, Caspell-Garcia C, Coffey CS, Siderowf A, Trojanowski JQ, Shaw LM, Seibyl J, Singleton A, Toga AW, Galasko D, Foroud T, Tosun D, Poston K, Weintraub D, Mollenhauer B, Tanner …
• Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease.
  Movement disorders : official journal of the Movement Disorder Society 2019 Mollenhauer B, Caspell-Garcia CJ, Coffey CS, Taylor P, Singleton A, Shaw LM, Trojanowski JQ, Frasier M, Simuni T, Iranzo A, Oertel W, Siderowf A, Weintraub D, Seibyl J, Toga AW, Tanner CM, Kieburtz K,…
• Regional Gray Matter Volume Links Rest-Activity Rhythm Fragmentation With Past Cognitive Decline.
  The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry 2019 Smagula SF, Chahine L, Metti A, Rangarajan A, Aizenstein HJ, Tian Q, Rosano C
• Cortical thinning in patients with REM sleep behavior disorder is associated with clinical progression.
  NPJ Parkinson's disease 2019 Pereira JB, Weintraub D, Chahine L, Aarsland D, Hansson O, Westman E
• Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI).
  Parkinsonism & related disorders 2019 Prakash N, Caspell-Garcia C, Coffey C, Siderowf A, Tanner CM, Kieburtz K, Mollenhauer B, Galasko D, Merchant K, Foroud T, Chahine LM, Weintraub D, Casaceli C, Dorsey R, Wilson R, Herzog M, Daegele N, …
• Basic clinical features do not predict dopamine transporter binding in idiopathic REM behavior disorder.
  NPJ Parkinson's disease 2019 Chahine LM, Iranzo A, Fernández-Arcos A, Simuni T, Seedorff N, Caspell-Garcia C, Amara AW, Comella C, Högl B, Hamilton J, Marek K, Mayer G, Mollenhauer B, Postuma R, Tolosa E, Trenkwalder C, Videnovic…
• Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures.
  Journal of Parkinson's disease 2019 Chahine LM, Siderowf A, Barnes J, Seedorff N, Caspell-Garcia C, Simuni T, Coffey CS, Galasko D, Mollenhauer B, Arnedo V, Daegele N, Frasier M, Tanner C, Kieburtz K, Marek K, The Parkinson’s …
• Revision of Diagnosis in Early Parkinsonism with Abnormal Dopamine Transporter Imaging.
  Journal of Parkinson's disease 2019 Massa J, Chahine LM
• Self-reported physical activity levels and clinical progression in early Parkinson's disease.
  Parkinsonism & related disorders 2018 Amara AW, Chahine L, Seedorff N, Caspell-Garcia CJ, Coffey C, Simuni T, Parkinson's Progression Markers Initiative
• The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort.
  Annals of clinical and translational neurology 2018 Marek K, Chowdhury S, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Simuni T, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, …
• Modifiable vascular risk factors, white matter disease and cognition in early Parkinson's disease.
  European journal of neurology 2018 Chahine LM, Dos Santos C, Fullard M, Scordia C, Weintraub D, Erus G, Rosenthal L, Davatzikos C, McMillan CT
• Immunohistochemical Method and Histopathology Judging for the Systemic Synuclein Sampling Study (S4).
  Journal of neuropathology and experimental neurology 2018 Beach TG, Serrano GE, Kremer T, Canamero M, Dziadek S, Sade H, Derkinderen P, Corbillé AG, Letournel F, Munoz DG, White CL, Schneider J, Crary JF, Sue LI, Adler CH, Glass MJ, Intorcia AJ, Walker JE, …
• Cognition among individuals along a spectrum of increased risk for Parkinson's disease.
  PloS one 2018 Chahine LM, Urbe L, Caspell-Garcia C, Aarsland D, Alcalay R, Barone P, Burn D, Espay AJ, Hamilton JL, Hawkins KA, Lasch S, Leverenz JB, Litvan I, Richard I, Siderowf A, Coffey CS, Simuni T, Weintraub …
• Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort.
  Movement disorders : official journal of the Movement Disorder Society 2018 Simuni T, Siderowf A, Lasch S, Coffey CS, Caspell-Garcia C, Jennings D, Tanner CM, Trojanowski JQ, Shaw LM, Seibyl J, Schuff N, Singleton A, Kieburtz K, Toga AW, Mollenhauer B, Galasko D, Chahine LM, …
• Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4).
  Journal of Parkinson's disease 2018 Chahine LM, Beach TG, Seedorff N, Caspell-Garcia C, Coffey CS, Brumm M, Adler CH, Serrano GE, Linder C, Mosovsky S, Foroud T, Riss H, Ecklund D, Seibyl J, Jennings D, Arnedo V, Riley L, Dave KD, …
• APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.
  Movement disorders : official journal of the Movement Disorder Society 2017 Tropea TF, Xie SX, Rick J, Chahine LM, Dahodwala N, Doshi J, Davatzikos C, Shaw LM, Van Deerlin V, Trojanowski JQ, Weintraub D, Chen-Plotkin AS
• Cognition and the course of prodromal Parkinson's disease.
  Movement disorders : official journal of the Movement Disorder Society 2017 Weintraub D, Chahine LM, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D, PARS Investigators
• Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort.
  Journal of neurology, neurosurgery, and psychiatry 2017 Simuni T, Caspell-Garcia C, Coffey CS, Weintraub D, Mollenhauer B, Lasch S, Tanner CM, Jennings D, Kieburtz K, Chahine LM, Marek K
• Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next?
  Movement disorders clinical practice 2017 Chahine LM, Stern MB
• Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series.
  NPJ Parkinson's disease 2017 Humbert M, Findley J, Hernandez-Con M, Chahine LM
• Portable objective assessment of upper extremity motor function in Parkinson's disease.
  Parkinsonism & related disorders 2017 Chahine LM, Uribe L, Hogarth P, McNames J, Siderowf A, Marek K, Jennings D
• Treatment of Sleep Dysfunction in Parkinson's Disease.
  Current treatment options in neurology 2017 Amara AW, Chahine LM, Videnovic A
• Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease.
  PloS one 2017 Caspell-Garcia C, Simuni T, Tosun-Turgut D, Wu IW, Zhang Y, Nalls M, Singleton A, Shaw LA, Kang JH, Trojanowski JQ, Siderowf A, Coffey C, Lasch S, Aarsland D, Burn D, Chahine LM, Espay AJ, Foster ED, …
• The Systemic Synuclein Sampling Study: toward a biomarker for Parkinson's disease.
  Biomarkers in medicine 2017 Visanji NP, Mollenhauer B, Beach TG, Adler CH, Coffey CS, Kopil CM, Dave KD, Foroud T, Chahine L, Jennings D, Systemic Synuclein Sampling Study (S4)
• Statins and Cognition in Parkinson's Disease.
  Journal of Parkinson's disease 2017 Deck BL, Rick J, Xie SX, Chen-Plotkin A, Duda JE, Morley JF, Chahine LM, Dahodwala N, Trojanowski JQ, Weintraub D
• Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.
  Parkinsonism & related disorders 2016 Chahine LM, Xie SX, Simuni T, Tran B, Postuma R, Amara A, Oertel WH, Iranzo A, Scordia C, Fullard M, Linder C, Purri R, Darin A, Rennert L, Videnovic A, Del Riva P, Weintraub D
• Effects of STN DBS for Parkinson's disease on restless legs syndrome and other sleep-related measures.
  Parkinsonism & related disorders 2011 Chahine LM, Ahmed A, Sun Z
• Rasagiline in Parkinson's disease.
  International review of neurobiology 2011 Chahine LM, Stern MB
• Mental health care in Lebanon: policy, plans and programmes.
  Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2009 Chahine LM, Chemali Z
• Palliative care needs of patients with neurologic or neurosurgical conditions.
  European journal of neurology 2008 Chahine LM, Malik B, Davis M
• Older adult care in Lebanon: towards stronger and sustainable reforms.
  Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit 2008 Chemali Z, Chahine LM, Sibai AM
• Dementia and depression among nursing home residents in Lebanon: a pilot study.
  International journal of geriatric psychiatry 2007 Chahine LM, Bijlsma A, Hospers AP, Chemali Z
• Familial mesial temporal lobe epilepsy maps to chromosome 4q13.2-q21.3.
  Neurology 2007 Hedera P, Blair MA, Andermann E, Andermann F, D'Agostino D, Taylor KA, Chahine L, Pandolfo M, Bradford Y, Haines JL, Abou-Khalil B
• Hyperekplexia in Kurdish families: a possible GLRA1 founder mutation.
  Neurology 2006 Sirén A, Legros B, Chahine L, Misson JP, Pandolfo M
• Du rire aux larmes: pathological laughing and crying in patients with traumatic brain injury and treatment with lamotrigine.
  Epilepsy & behavior : E&B 2006 Chahine LM, Chemali Z